WINTON GROUP Ltd - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$23,000
-53.1%
14,798
-27.7%
0.00%
-66.7%
Q1 2021$49,000
-15.5%
20,456
+3.3%
0.00%
-25.0%
Q4 2020$58,000
-50.8%
19,799
-74.2%
0.00%0.0%
Q3 2020$118,000
-54.3%
76,830
-25.5%
0.00%
-42.9%
Q2 2020$258,000
+48.3%
103,059
+20.5%
0.01%
+40.0%
Q1 2020$174,000
-4.4%
85,525
+45.6%
0.01%
+66.7%
Q4 2019$182,000
+2.2%
58,751
+10.0%
0.00%
+50.0%
Q3 2019$178,000
+22.8%
53,409
+5.9%
0.00%
-33.3%
Q1 2019$145,00050,4550.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 896,137$4,185,0002.27%
Wellington Shields Capital Management, LLC 888,333$4,149,0000.67%
Manatuck Hill Partners, LLC 15,090$70,0000.03%
IHT Wealth Management, LLC 10,725$50,0000.01%
Perceptive Advisors 43,682$204,0000.01%
ALPS ADVISORS INC 153,234$716,0000.01%
ROYCE & ASSOCIATES LP 78,742$368,0000.00%
MEEDER ASSET MANAGEMENT INC 5,863$28,0000.00%
Tower Research Capital LLC (TRC) 5,974$28,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 18,585$86,7920.00%
View complete list of CASI PHARMACEUTICALS INC shareholders